Dai, Z., Zhang, N., Zhou, R., Zhang, H., Zhang, L., Wang, Z., . . . Cheng, Q. (2023). Identification of a single cell-based signature for predicting prognosis risk and immunotherapy response in patients with glioblastoma. Clinical immunology (Orlando, Fla.), 251, 109345. https://doi.org/10.1016/j.clim.2023.109345
Style de citation ChicagoDai, Ziyu, et al. "Identification of a Single Cell-based Signature for Predicting Prognosis Risk and Immunotherapy Response in Patients with Glioblastoma." Clinical Immunology (Orlando, Fla.) 251 (2023): 109345. https://dx.doi.org/10.1016/j.clim.2023.109345.
Style de citation MLADai, Ziyu, et al. "Identification of a Single Cell-based Signature for Predicting Prognosis Risk and Immunotherapy Response in Patients with Glioblastoma." Clinical Immunology (Orlando, Fla.), vol. 251, 2023, p. 109345.